JNNP 神经病学· Akeret, K., Buzzi, R. M., Gentinetta, T., Saxenhofer, M., Kronthaler, D., Colombo, E., Grob, A., Thomson, B., Schwendinger, N., Abdulazim, A., Haegler, J., Canzanella, G., Kaelin, V., Baettig, L., Wiggenhauser, L. M., Wostrack, M., Albrecht, C., Gmeiner, M., Shawarba, J., Couto, D., Wymann, S., Wassmer, A., Illi, M., Bieri, K., Rössler, K., Gruber, A., Meyer, B., Roder, C., Hostettler, I. C., Grüter, B. E., Etminan, N., Regli, L., Keller, E., Held, U., Schaer, D. J., Hugelshofer, M., for the HeMoVal Research Group, Grüttner-Durmaz, Menz, Chiavi, Humar, Doormaal, Schubert, Irmak, Bozinov, Wang, Jörger, Eisenkolb, Helmers, Wirz, Heg, Mahler·· 2026-10-13精选AI 评分68
脑脊液血红蛋白作为动脉瘤性蛛网膜下腔出血继发性脑损伤监测生物标志物:前瞻性国际多中心验证研究(HeMoVal)
Cerebrospinal fluid haemoglobin as a monitoring biomarker for secondary brain injury after aneurysmal subarachnoid haemorrhage: prospective international multicentre validation study (HeMoVal)
AI 导读
HeMoVal研究纳入8个神经外科中心的366例动脉瘤性蛛网膜下腔出血患者,评估脑脊液血红蛋白(CSF-Hb)作为继发性脑损伤(SAH-SBI)监测生物标志物的价值。
推荐理由
多中心队列验证显示脑脊液血红蛋白对动脉瘤性蛛网膜下腔出血继发性脑损伤的同日鉴别能力有限,与单中心研究结果差异明显。
来源:JNNP 神经病学 · jnnp.bmj.com